Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Jasper Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oruka Therapeutics Inc. June 2, 202699.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Oruka Therapeutics Inc. | Option exercise | +25,000 | $7.80 | $195,000 |
| Nov 2, 2026 | Oruka Therapeutics Inc. | Open-market sale | −6,466 | $94.77 | $612,794 |
| Nov 2, 2026 | Oruka Therapeutics Inc. | Open-market sale | −15,036 | $95.64 | $1,437,987 |
| Nov 2, 2026 | Oruka Therapeutics Inc. | Open-market sale | −2,442 | $96.70 | $236,147 |
| Nov 2, 2026 | Oruka Therapeutics Inc. | Open-market sale | −756 | $97.45 | $73,676 |
| Nov 2, 2026 | Oruka Therapeutics Inc. | Open-market sale | −300 | $98.40 | $29,521 |
| Oct 1, 2026 | Oruka Therapeutics Inc. | Option exercise | +25,000 | $7.80 | $195,000 |
| Oct 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −16,246 | $83.40 | $1,354,882 |
| Oct 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −8,554 | $84.03 | $718,755 |
| Oct 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −200 | $84.78 | $16,956 |
| Sep 15, 2026 | Oruka Therapeutics Inc. | Open-market sale | −2,452 | $95.71 | $234,681 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Option exercise | +75,000 | $7.80 | $585,000 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −6,604 | $90.79 | $599,577 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −63,596 | $91.90 | $5,844,472 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −4,800 | $92.44 | $443,712 |
Questions about Lawrence Otto Klein
What boards is Lawrence Otto Klein on?
Lawrence Otto Klein sits on the boards of Jade Biosciences Inc., Jasper Therapeutics Inc. and Oruka Therapeutics Inc.
What company is Lawrence Otto Klein the CEO of?
Lawrence Otto Klein has been President and CEO of Oruka Therapeutics Inc. since August 2024.
How long has Lawrence Otto Klein served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.